| [1] |
Albertsmeier M, Rauch A, Roeder F, et al. External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis[J]. Ann Surg Oncol, 2018, 25(3): 754-767.
|
| [2] |
Bonvalot S, Gronchi A, Le Péchoux C, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma(EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial[J]. Lancet Oncol, 2020, 21(10): 1366-1377.
|
| [3] |
Callegaro D, Raut CP, Ajayi T, et al. Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial(STRASS) Versus Off-trial(STREXIT) Results[J]. Ann Surg, 2023, 278(1): 127-134.
|
| [4] |
Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database[J]. Lancet Oncol, 2016, 17(7): 966-975.
|
| [5] |
Zhang M, Crago A, Yoon SS, et al. Feasibility of Preoperative Dose-Painting Intensity Modulated Radiation Therapy(IMRT) for Borderline-Resectable Primary Retroperitoneal Sarcoma[J]. Ann Surg Oncol, 2022, 29(11): 7115-7121.
|
| [6] |
潘向欧，张莉，侯佳舟, 等. 切除困难或不可切除原发性腹膜后软组织肉瘤术前转化放射治疗的研究[J]. 外科理论与实践, 2022, 27(6): 530-533.
|
| [7] |
Liveringhouse CL, Palm RF, Bryant JM, et al. Neoadjuvant Simultaneous Integrated Boost Radiation Therapy Improves Clinical Outcomes for Retroperitoneal Sarcoma[J]. Int J Radiat Oncol Biol Phys, 2023, 117(1): 123-138.
|
| [8] |
Chung C, Trofimov A, Adams J, et al. Comparison of 3D Conformal Proton Therapy, Intensity-Modulated Proton Therapy, and Intensity-Modulated Photon Therapy for Retroperitoneal Sarcoma[J]. Sarcoma, 2022, 2022: 5540615.
|
| [9] |
DeLaney TF, Chen YL, Baldini EH, et al. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas[J]. Adv Radiat Oncol, 2017, 2(1): 85-93.
|
| [10] |
O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial[J]. Lancet, 2002, 359(9325): 2235-2241.
|
| [11] |
von Mehren M, Kane JM, Agulnik M, et al. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2022, 20(7): 815-833.
|
| [12] |
中国临床肿瘤学会指南工作委员会. 骨与软组织肿瘤诊疗指南2024[R]. 北京：人民卫生出版社, 2024.
|
| [13] |
Littau MJ, Kulshrestha S, Bunn C, et al. The importance of the margin of resection and radiotherapy in retroperitoneal liposarcoma [J]. Am J Surg, 2021, 221(3): 554-560.
|
| [14] |
Kim HJ, Koom WS, Cho J, et al. Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma[J]. Yonsei Med J, 2018, 59(9): 1049-1056.
|
| [15] |
Bates JE, Dhakal S, Mazloom A, et al. The Benefit of Adjuvant Radiotherapy in High-grade Nonmetastatic Retroperitoneal Soft Tissue Sarcoma: A SEER Analysis[J]. Am J Clin Oncol, 2018, 41(3): 274-279.
|
| [16] |
Paumier A, Bonvalot S, Beaudré A, et al. [Intensity modulated radiotherapy as adjuvant post-operative treatment for retroperitoneal sarcoma: acute toxicity][J]. Cancer Radiother, 2011, 15(5): 413-420.
|
| [17] |
Yu JI, Lim DH, Park HC, et al. Effectiveness and Safety of Tissue Expander for Adjuvant Helical Tomotherapy in Curatively Resected Retroperitoneal Sarcoma[J]. Anticancer Res, 2018, 38(4): 2447-2453.
|
| [18] |
Park H, Lee S, Kim B, et al. Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control[J]. Medicine(Baltimore), 2016, 95(32): e4435.
|
| [19] |
Reid J, Smith R, Borg M, et al. Feasibility of spacers to facilitate postoperative radiotherapy for retroperitoneal sarcomas[J]. J Med Imaging Radiat Oncol, 2017, 61(6): 812-818.
|
| [20] |
Serizawa I, Kusano Y, Kano K, et al. Three cases of retroperitoneal sarcoma in which bioabsorbable spacers(bioabsorbable polyglycolic acid spacers) were inserted prior to carbon ion radiotherapy[J]. J Radiat Res, 2022, 63(2): 296-302.
|
| [21] |
Roeder F, Morillo V, Saleh-Ebrahimi L, et al. Intraoperative radiation therapy(IORT) for soft tissue sarcoma-ESTRO IORT Task Force/ ACROP recommendations[J]. Radiother Oncol, 2020, 150: 293-302.
|
| [22] |
van Leeuwen CM, Oei AL, Crezee J, et al. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies[J]. Radiat Oncol, 2018, 13(1): 96.
|
| [23] |
Gieschen HL, Spiro IJ, Suit HD, et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma[J]. Int J Radiat Oncol Biol Phys, 2001, 50(1): 127-131.
|
| [24] |
Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial[J]. Arch Surg, 1993, 128(4): 402-410.
|
| [25] |
Murray Brunt A, Haviland JS, Wheatley DA, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks(FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial[J]. Lancet, 2020, 395(10237): 1613-1626.
|
| [26] |
Widmark A, Gunnlaugsson A, Beckman L, et al. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial[J]. Lancet, 2019, 394(10196): 385-395.
|
| [27] |
van Leeuwen CM, Oei AL, Crezee J, et al. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies[J]. Radiat Oncol, 2018, 13(1): 96.
|
| [28] |
Roohani S, Ehret F, Kobus M, et al. Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review[J]. Radiat Oncol, 2022, 17(1): 159.
|
| [29] |
Wong RX, Yang VSW, Chia CS, et al. Feasibility and safety study of ultra-hypofractionated neoadjuvant radiotherapy to margins-at-risk in retroperitoneal sarcoma[J]. Radiat Oncol J, 2025, 43(1): 6-12.
|
| [30] |
Hijab A, Tova Y, Alani S, et al. CT-Guided Online Adaptive Stereotactic Body Radiotherapy(SBRT) for Retroperitoneal Sarcoma After Previous Radiotherapy: A Case Report[J]. Cureus, 2024, 16(9): e69239.
|
| [31] |
Lu M, Yao W, Zhang T, et al. Feasibility and Efficacy of Microwave Ablation Combined with Iodine-125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience[J]. Oncologist, 2017, 22(12): 1500-1505.
|
| [32] |
Gronchi A, Strauss DC, Miceli R, et al. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group[J]. Ann Surg, 2016, 263(5): 1002-1009.
|
| [33] |
Tan MC, Brennan MF, Kuk D, et al. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma[J]. Ann Surg, 2016, 263(3): 593-600.
|
| [34] |
Haas RLM, Bonvalot S, Miceli R, et al. Radiotherapy for retroperitoneal liposarcoma: a report from the Transatlantic Retroperitoneal Sarcoma Working Group[J]. Cancer, 2019, 125(8): 1290-1300.
|
| [35] |
Gronchi A, Hindi N, Cruz J, et al. Trabectedin and RAdiotherapy in Soft Tissue Sarcoma(TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish(GEIS), Italian(ISG), French (FSG) Sarcoma Groups[J]. EClinicalMedicine, 2019, 9: 35-43.
|
| [36] |
Lansu J, Bovée JVMG, Braam P, et al. Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial[J]. JAMA Oncol, 2021, 7(1): e205865.
|
| [37] |
Sobiborowicz A, Spałek MJ, Czarnecka AM, et al. Definitive Radiotherapy in the Management of Non-Resectable or Residual Retroperitoneal Sarcomas: Institutional Cohort Analysis and Systematic Review[J]. Cancer Control, 2021, 28: 1073274820983028.
|
| [38] |
Gogineni E, Chen H, Istl AC, et al. Comparative In Silico Analysis of Ultra-Hypofractionated Intensity-Modulated Photon Radiotherapy (IMRT) Versus Intensity-Modulated Proton Therapy(IMPT) in the Pre-Operative Treatment of Retroperitoneal Sarcoma[J]. Cancers (Basel), 2023, 15(13): 3482.
|
| [39] |
Seidensaal K, Kieser M, Hommertgen A, et al. Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial[J]. Trials, 2021, 22(1): 134.
|
| [40] |
王征，包慈航，蒋国梁. 质子重离子放射治疗在腹膜后肉瘤治疗中的价值[J]. 外科理论与实践, 2022, 27(6): 506-510.
|
| [41] |
Ming X, Wang W, Shahnazi K, et al. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy[J]. Int J Radiat Biol, 2022, 98(2): 183-190.
|
| [42] |
Vidri RJ, Howell KJ, Meyer JE, et al. Initial Clinical Experience With Novel Directional Low-Dose Rate Brachytherapy for Retroperitoneal Sarcoma[J]. J Surg Res, 2021, 268: 411-418.
|
| [43] |
Weichselbaum RR, Liang H, Deng L, et al. Radiotherapy and immunotherapy: a beneficial liaison?[J]. Nat Rev Clin Oncol, 2017, 14(6): 365-379.
|
| [44] |
Arina A, Gutiontov SI, Weichselbaum RR. Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite"[J]. Clin Cancer Res, 2020, 26(12): 2777-2782.
|
| [45] |
Roland CL, Nassif Haddad EF, Keung EZ, et al. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma[J]. Nat Cancer, 2024, 5(4): 625-641.
|
| [46] |
Wachsberger P, Burd R, Dicker AP. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction[J]. Clin Cancer Res, 2003, 9(6): 1957-1971.
|
| [47] |
Yoon SS, Duda DG, Karl DL, et al. Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas[J]. Int J Radiat Oncol Biol Phys, 2011, 81(4): 1081-1090.
|